FIELD: medicine.
SUBSTANCE: as an ANGPTL4 antagonist, anti-ANGPTL4-antibody is used. The invention allows for making the ANGPTL4 antagonist able to inhibit hepatocyte proliferation and cell adhesion, and inhibiting ANGPTL4 in hepatocytes or hepatocyte precursors.
EFFECT: improved properties of the compound.
4 cl, 20 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANGIOPOIETIC ANGIOPOIETIN-LIKE PROTEIN 4 INHIBITORS, IN COMBINATIONS AND APPLICATION | 2005 |
|
RU2392966C2 |
| MODULATORS OF HEPATOCYTE GROWTH FACTOR ACTIVATOR | 2005 |
|
RU2418004C2 |
| METHODS AND COMPOSITIONS FOR ACTIVATION MODULATION OF HEPATOCYTE GROWTH FACTOR | 2005 |
|
RU2405041C2 |
| NEW COMPOSITION AND METHODS FOR THERAPY OF IMMNUNE-ASSOCIATED DISEASES WITH IMMUNITY | 2004 |
|
RU2375078C2 |
| METHODS OF INHIBITING OCULAR ANGIOGENESIS | 2009 |
|
RU2530583C2 |
| INHIBITION OF TUMOUR METASTASES BY ANTIBODIES AGAINST NEUROPILINE-2 | 2007 |
|
RU2437677C2 |
| METHOD OF INHIBITING ANGIOGENESIS BY EGFL8 ANTAGONISTS | 2009 |
|
RU2486200C2 |
| ANGIOGENESIS INHIBITION | 2008 |
|
RU2471498C2 |
| ANTI-CCR2 ANTIBODIES | 2009 |
|
RU2547595C2 |
| TECHNIQUES AND COMPOSITIONS USED TO INHIBIT αβ-CAUSED ANGIOGENESIS | 1997 |
|
RU2195312C2 |
